Delivery Order SPE2DR25D3005-SPE2DR26FP7JD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,060.20 to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Aponvie 32 mg/4.4 mL vials. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, with an ultimate completion date of November 10, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $16,208.20 delivery order contract (4570030738) to AmerisourceBergen Drug Corp on November 17, 2025, for pharmaceutical products and related medical supplies. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, represents a competitive award with no set-aside designation. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $3,471.02 to AmerisourceBergen Drug Corp for the supply of Aponvie 32 mg/4.4 mL vials. The order was competitively awarded without a set-aside designation and is scheduled for completion by September 11, 2025. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026...
- The Defense Logistics Agency awarded a delivery order valued at $47,006.91 to AmerisourceBergen Drug Corp on November 18, 2025, for pharmaceutical products and medical supplies under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 19, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp on November 4, 2025, for pharmaceutical products and supplies under its Pharmaceutical PV Division program. This firm fixed-price delivery order, issued to the vendor's Corporate Office location in Conshohocken, Pennsylvania, represents a child contract with an ultimate completion date of November 5, 2025. The award was competitively procured without set-aside designations, reflecting...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $15,033.30 delivery order (Contract 4569946721) to AmerisourceBergen Drug Corp on November 7, 2025, with completion scheduled for November 10, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on the vendor's demonstrated capabilities. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform all work at its...
- The Defense Logistics Agency awarded a delivery order valued at $3,184.32 to AmerisourceBergen Drug Corp on November 14, 2025, under a firm fixed-price contract type. The order, designated as a non-set-aside competitive award, is scheduled for completion by November 17, 2025, with performance occurring at the contractor's Conshohocken, Pennsylvania location. This delivery order represents a child contract action under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $48,521.33 to AmerisourceBergen Drug Corp for pharmaceutical products and medical supplies. This firm fixed price delivery order, awarded on November 14, 2025, with an ultimate completion date of the same day, represents a child order under the company's larger indefinite delivery contract vehicle with DLA. The award utilizes no set-aside designation and reflects competitive procurement practices. The place of performance is...
- The Defense Logistics Agency awarded a $4,417 delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for pharmaceutical products and medical supplies. This firm fixed-price, competitively awarded delivery order is scheduled for completion by November 10, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $26,087.82 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, on November 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of November 19, 2025, was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP7JDDelivery Order
The Defense Logistics Agency awarded a $6,903.91 delivery order to AmerisourceBergen Drug Corp for Aponvie 32 mg/4.4 mL vials on November 20, 2025, with completion scheduled for November 21, 2025. This firm fixed price contract represents a non-set-aside award issued under open competition and is characterized as a child contract, indicating it derives from a larger contract vehicle. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a global pharmaceutical support contract enabling the company to supply a broad spectrum of medications, vaccines, and medical supplies to support military healthcare programs and other federal healthcare systems including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen Drug Corp's status as a major pharmaceutical distributor and established federal contractor demonstrates its capability to fulfill specialized pharmaceutical procurement requirements through competitive award processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.9k | 11/20/25 |